When Is Thrombophilia Testing Appropriate and How Can the Evidence Guide Clinical Care? – ISTH
International Society on Thrombosis and Haemostasis (ISTH) shared a post on LinkedIn:
“When is thrombophilia testing appropriate and how can the evidence help guide clinical care?
In this expert panel from World Thrombosis Day, presented in partnership with Sysmex Europe, leading voices in thrombosis explore evidence based approaches to thrombophilia screening and management.
Featuring Lana Castellucci, and Cihan Ay, with moderator Andreas Rechner, the discussion covers hereditary thrombophilia, Factor V Leiden, antiphospholipid syndrome (APS), appropriate testing, clinical management and future directions in thrombosis care.
Watch the full 45 minute discussion and deepen your understanding of this evolving area of thrombosis care.”
Stay updated with Hemostasis Today.
-
Sep 10, 2026, 14:21Seth Green: Testosterone Replacement Therapy and VTE Risk When Is the Risk Highest
-
Sep 10, 2026, 13:56Sumyea Kabir: Wet Hijama and Blood Donation Why Deferral Matters
-
Sep 10, 2026, 11:56William Pao: Celebrating a Landmark Breakthrough in Hemophilia Care
-
Sep 10, 2026, 11:25Andreas Glenthøj: New Sickle Cell Trait Data in UpToDate
-
Sep 10, 2026, 10:53A New Era of Hemophilia Screening and Diagnosis in Women and Girls – ISTH
-
Sep 10, 2026, 10:03Investing in Youth, Transforming Hemophilia Care – WFH
-
Sep 10, 2026, 09:51Ronke Oke BEM: 20 Years of Newborn Sickle Cell Screening in England
-
Sep 10, 2026, 09:41Seunghwan Song: Hemlibra and the Science That Changed Hemophilia A Care
-
Sep 10, 2026, 09:20Mark Dawson: A Radical Rethink of Hemophilia Treatment